Treatment of basal cell carcinoma intralesionally with...

Details Treatment of basal cell carcinoma intralesionally with... Treatment of basal cell carcinoma intralesionally with...

A - Human Necessities

61

K

167/103.1

A61K 38/21 (2006.01)

Patent

CA 1295243

ABSTRACT Human basal cell carcinoma is successfully treated by intralesional administration of recombinant human alpha interferon, especially interferon alfa-2b. The preparation of suitable pharmaceutical compositions is disclosed.

537837

Affiliated with

Also associated with

Rating

Treatment of basal cell carcinoma intralesionally with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of basal cell carcinoma intralesionally with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of basal cell carcinoma intralesionally with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1215906